MabVax Therapeutics, Incadmin2022-01-17T17:33:21+00:00 Project Description Follow-On Offering Common Stock & Warrants $2,750,000 Sole Book-Runner October 2015 Related Project Details Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInTumblrPinterestVkEmail